Cellectis (CLLS) Misses Q4 EPS by 7c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.22 million versus the consensus estimate of $21.71 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Simmons First National Corp (SFNC) Misses Q2 EPS by 2c
• Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
• ASP Isotopes (ASPI) files for 23.16M share offering by selling stockholders